Stockscreener 앱 받기
2.48
5.53%
0.13
시간 외 거래:
2.42
-0.06
-2.42%
전일 마감가:
$2.35
열려 있는:
$2.32
하루 거래량:
33,974
Relative Volume:
0.95
시가총액:
$10.22M
수익:
$1.02M
순이익/손실:
$-10.36M
주가수익비율:
-0.3983
EPS:
-6.2265
순현금흐름:
$-8.76M
1주 성능:
+2.48%
1개월 성능:
-7.46%
6개월 성능:
-32.43%
1년 성능:
-4.25%
1일 변동 폭
$2.32
$2.48
1주일 범위
$2.3001
$2.6399
52주 변동 폭
$1.99
$6.78
SINTX 테크놀로지스 Stock (SINT) Company Profile
명칭
Sintx Technologies Inc
전화
801-839-3516
주소
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.48 | 9.69M | 1.02M | -10.36M | -8.76M | -6.2265 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
SINTX 테크놀로지스 Stock (SINT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 개시 | H.C. Wainwright | Buy |
| 2019-09-12 | 개시 | Ascendiant Capital Markets | Buy |
SINTX 테크놀로지스 주식(SINT)의 최신 뉴스
SiNtx Technologies, Inc.Common Stock (NQ: SINT - FinancialContent
SINT SiNtx Technologies posts narrow Q4 2025 EPS miss, shares rally 15.87 percent on positive investor sentiment.Competitive Advantage - newser.com
SINT Price Today: SiNtx Technologies, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
SINT Technical Analysis & Stock Price Forecast - Intellectia AI
SINT Forecast, Price Target & Analyst Ratings | SINTX TECHNOLOGIES INC (NASDAQ:SINT) - ChartMill
SiNtx Technologies (SINT) Stock: Buy, Sell, Hold? (+0.37%) 2026-04-18Undervalued Stocks - Xã Thanh Hà
Robert Ryan Elmore Net Worth (2026) - GuruFocus
H.C. Wainwright Initiates Sintx Technologies(SINT.US) With Buy Rating, Announces Target Price $10 - 富途牛牛
Sintx Technologies (SINT) president granted 4,910 common shares as equity award - Stock Titan
SINT Initiates Coverage On SINTX Technologies -- Price Target An - GuruFocus
Published on: 2026-04-14 02:01:43 - baoquankhu1.vn
Trend Report: Can Sintx Technologies Inc disrupt its industryBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Sintx Technologies (NASDAQ:SINT) Given New $12.00 Price Target at Ascendiant Capital Markets - Defense World
SINT Maintains 'Buy' Rating; Target Price Adjusted to $12 by Asc - GuruFocus
Setup Watch: Can Sintx Technologies Inc stock double in the next yearMarket Trend Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Total debt per share of SINTX Technologies, Inc. – LSE:0A8S - TradingView — Track All Markets
EBITDA per share of SINTX Technologies, Inc. – LSE:0A8S - TradingView
SINT Stock Analysis: SiNtx Technologies Inc. MedTech Play at $2.52 After 1.18% Daily Dip - UBND thành phố Hải Phòng
Insider Sell: Can Sintx Technologies Inc disrupt its industryDip Buying & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Earnings Update: What is the PEG ratio of Sintx Technologies IncMarket Risk Report & Technical Confirmation Alerts - baoquankhu1.vn
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution - Orthopedics This Week
SINTX completes first human implant, names new president By Investing.com - Investing.com Australia
Sintx Technologies 2025 10‑K: Revenue $1.018M, Net Loss $10.364M - TradingView
SINTX completes first human implant, names new president - Investing.com
After its first human foot implant, SINTX shifts to 2026 rollout - Stock Titan
Sintx Technologies (SINT) to Release Quarterly Earnings on Monday - Defense World
SINTX Technologies: Advanced Silicon Nitride Ceramics for Biomedical, Technical, and Antipathogenic Applications 72 - Minichart
SINTX Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sintx Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
SINTX Technologies (NASDAQ: SINT) outlines 2025 losses, cash and silicon nitride strategy - Stock Titan
SINTX completes first surgery with foot and ankle implant system By Investing.com - Investing.com India
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - Orthopedics This Week
SINTX Technologies (SINT) Achieves Milestone with First Surgical Use of New System - GuruFocus
SINTX completes first surgery with foot and ankle implant system - Investing.com
Sintx Technologies announces first-in-human surgery using FDA-cleared Sinaptic® Foot & Ankle Implant - marketscreener.com
A new foot implant reaches its first patient after FDA clearance - Stock Titan
Sintx Technologies (SINT) president granted 107,143 RSUs under 2025 equity plan - Stock Titan
SINT PE Ratio & Valuation, Is SINT Overvalued - Intellectia AI
Sintx Technologies, Inc. revenue 2020 to 2024 - Statista
SINTX Technologies Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Published on: 2026-03-11 05:25:53 - baoquankhu1.vn
Sintx Technologies director Lyons buys shares worth $24,092 By Investing.com - Investing.com South Africa
Sintx Technologies director Lyons buys shares worth $24,092 - Investing.com
Director Lyons adds 8,292 Sintx Technologies (SINT) shares in open-market buys - Stock Titan
Earnings Beat: What is the PEG ratio of Sintx Technologies Inc2025 Winners & Losers & Free Reliable Trade Execution Plans - baoquankhu1.vn
SINTX focuses on filament and partnerships: New president to bring SiN/PEEK into 3D production - 3Druck.com
SINT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SINTX Technologies names Ryan Elmore President to drive commercial expansion of SiN biomaterials - VoxelMatters
SINTX 테크놀로지스 (SINT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):